-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation